CTLA4 and synovial sarcoma: For this reason, abatacept (a humanized cytotoxic T-lymphocyte–associated antigen 4 (CTLA4)–IgG1 fusion protein binding CD80 or CD86 and inhibiting the CD28 co-stimulatory pathway on T cell therapy) has been evaluated for SS treatment [24,25,26].